EP3509637
METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
:
EP einkaleyfi: Þýðing ekki lögð inn:
5.9.2017:
27.11.2024:
17848753.4
:
4.9.2037
:
METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
5.9.2017
27.11.2024
:
Chugai Seiyaku Kabushiki Kaisha:
5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543, JP
:
F. Hoffmann-La Roche AG:
Grenzacherstrasse 124, 4070 Basel, CH
:
YONEYAMA, Koichiro:
Tokyo 103-8324, JP
:
SCHMITT, Christophe:
4070 Basel, CH
:
201662383933 P:
6.9.2016:
US
:
201662437281 P:
21.12.2016:
US
:
201762485514 P:
14.4.2017:
US
:
JP2017031933:
5.9.2017
:
A61K 39/395, A61P 7/04